- $1.60bn
- $1.69bn
- $2.90bn
Brief: Carter's Q4 Adjusted EPS USD 2.76 Vs. IBES Estimate USD 2.61
Carter's Inc expected to post earnings of $2.61 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Biomarin Pharmaceutical, Intuit, Penumbra
Brief: Carter’s, Inc. Announces Leadership Changes
Brief: Carter’s And Shipt Expand Partnership To Bring Same-Day Delivery During Holiday Season
U.S. RESEARCH ROUNDUP- Alnylam Pharmaceuticals, Labcorp, Vertex Pharmaceuticals
Carter's Inc reports results for the quarter ended in September - Earnings Summary
Brief: Carter's Q3 Adjusted EPS USD 1.84 Vs. IBES Estimate USD 1.54
Carter's Inc expected to post earnings of $1.54 a share - Earnings Preview
Carter's Inc reports results for the quarter ended in June - Earnings Summary
Brief: Carter's Q2 Adjusted EPS USD 0.64 Vs. IBES Estimate USD 0.53
Carter's Inc expected to post earnings of 53 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-First Republic, Charter Communications, FirstEnergy
Carter's reverses course on easing inflationary pressures
Apparel retailer Carter's down on dour Q2 forecast
Carter's Inc reports results for the quarter ended in March - Earnings Summary
Brief: Carter’s Inc Reports First Quarter Fiscal 2023 Results
Carter's Inc expected to post earnings of 59 cents a share - Earnings Preview
Carter's Inc expected to post earnings of 57 cents a share - Earnings Preview